HOOKIPA Pharma Inc banner

HOOKIPA Pharma Inc
NASDAQ:HOOK

Watchlist Manager
HOOKIPA Pharma Inc Logo
HOOKIPA Pharma Inc
NASDAQ:HOOK
Watchlist
Price: 1.06 USD -1.85% Market Closed
Market Cap: $13.1m

Wall Street
Price Targets

HOOK Price Targets Summary
HOOKIPA Pharma Inc

There are no price targets for HOOK.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
HOOKIPA Pharma Inc Competitors:
Price Targets
CDNA
CareDx Inc
35% Upside
KRNY
Kearny Financial Corp
25% Upside
RCKT
Rocket Pharmaceuticals Inc
68% Upside
PTGX
Protagonist Therapeutics Inc
-2% Downside

Revenue
Forecast

34% / Year
Past Growth
-39% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
34% / Year
Past Growth
-39% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

For the last 6 years the compound annual growth rate for HOOKIPA Pharma Inc's revenue is 34%. The projected CAGR for the next 3 years is -39%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-64%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-64%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HOOK's stock price target?
Not Available

HOOK doesn't have any price targets made by Wall Street professionals.

What is HOOKIPA Pharma Inc's Revenue forecast?
Projected CAGR
-39%

For the last 6 years the compound annual growth rate for HOOKIPA Pharma Inc's revenue is 34%. The projected CAGR for the next 3 years is -39%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett